Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS/TLRs/NF-κB Signaling Pathway in Mice

Liver injury caused by first-line anti-tuberculosis (anti-TB) drugs accounts for a high proportion of drug-induced liver injury (DILI), and gut microbiota and intestinal barrier integrity have been shown to be involved in the development of DILI. Magnesium isoglycyrrhizinate (MgIG) is the fourth-gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Jin-Yu, Ren, Huan, Chen, Hui-Qing, Xing, Kai, Xiao, Chen-Lin, Luo, Jian-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505492/
https://www.ncbi.nlm.nih.gov/pubmed/36145350
http://dx.doi.org/10.3390/ph15091130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505492/
https://www.ncbi.nlm.nih.gov/pubmed/36145350
http://dx.doi.org/10.3390/ph15091130

Ejemplares similares